| Promises and challenges of positron emission tomography for assessment of sarcoma in daily clinical practice. | |
| | |
MedLine Citation:
|
PMID: 18852082 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A correct histological diagnosis, careful staging and detection of tumour response to treatment are all crucial in the management of sarcomas. Imaging is important in all of these stages. Sarcomas have distinct biological and treatment-related features posing challenges for imaging. For example, size measurements may not adequately reflect response rates. Techniques which can measure tissue function rather than generate merely anatomical data such as positron emission tomography (PET) are rapidly gaining interest. We discuss the importance of imaging in different stages of patient management, emphasising the unique characteristics of sarcoma. Furthermore, we discuss the potential of PET for the various indications, focussing on therapy evaluation. |
| | |
Authors:
|
A C M van de Luijtgaarden; J W J de Rooy; L F de Geus-Oei; W T A van der Graaf; W J G Oyen |
Publication Detail:
|
Type: Journal Article; Review Date: 2008-10-04 |
Journal Detail:
|
Title: Cancer imaging : the official publication of the International Cancer Imaging Society Volume: 8 Spec No A ISSN: 1470-7330 ISO Abbreviation: Cancer Imaging Publication Date: 2008 |
Date Detail:
|
Created Date: 2008-10-14 Completed Date: 2008-11-14 Revised Date: 2010-10-05 |
Medline Journal Info:
|
Nlm Unique ID: 101172931 Medline TA: Cancer Imaging Country: England |
Other Details:
|
Languages: eng Pagination: S61-8 Citation Subset: IM |
Affiliation:
|
Department of Medical Oncology. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Bone Neoplasms
/
radionuclide imaging Fluorodeoxyglucose F18 / diagnostic use Gastrointestinal Stromal Tumors / radionuclide imaging Humans Magnetic Resonance Imaging Neoplasm Staging Positron-Emission Tomography Sarcoma / pathology, radionuclide imaging*, therapy |
| Chemical | |
Reg. No./Substance:
|
63503-12-8/Fluorodeoxyglucose F18 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer.
Next Document: Critical questions in the imaging of colorectal hepatic metastases.